E-drug: Training and promotion of ADR reporting
---------------------------------------------------------------------
Dear Colleagues,
The Nucleo de Farmacovigilancia do Centro (NFC) (Regional Unit of
the Portuguese National Pharmacovigilance System) is currently
undertaking a short-term study on training and promotion of Health
Professionals on spontaneous reporting of suspected adverse drug
reactions (ADR) in order to make recommendations on the best
practice in educating and informing Health Professionals in Portugal
on the subject.
Part of this study includes a review of the literature available on the
use of different methodologies to increase the number and the quality
of reports of suspected adverse drug reactions (ADR) by Health
Professionals.
In order to make this study as comprehensive as possible the NFC
would like to include updated information from those involved in
pharmacovigilance and drug information and would appreciate it if
those involved could respond the following questions:
1. Is your organisation responsible for promoting and training Health
Professionals on spontaneous adverse drug reactions reporting?
2. What training and promotional methods does your organisation use
to increase the number and quality of ADR reports received from
Health Professionals?
3. Which methods have been most successful in achieving the above
aims and how often are they organised?
4. If education sessions are used:
a. Which Health Professionals have been the main targets?
b. At what stage in their careers (ie. pre- or post-graduate)?
c. What specific content is included in these sessions?
(If a copy of the full presentations or the outline of the sessions
can be attached it would be very appreciated)
5. How has the success/failure of these training and promotional
methods been evaluated in the past?
6. For what other reasons is training and promotion provided by your
organisation to Health Professionals?
Please send responses by email to farmacovigilancia@nfc.pt or by
fax to +351-239-851839. Responses in english, french, spanish or
portuguese are welcomed.
Thank you very much, in advance, for your prompt reply and for your
interest in and support of this investigation.
Should you be interested in receiving the final report of this study, the
NFC would be glad to send you a copy once it has been completed.
Sincerely,
Germano Ferreira
Project Manager
Nucleo de Farmacovigilancia do Centro
Faculdade de Medicina da Universidade de Coimbra
Apartado 3020, 3001-401 Coimbra, Portugal
Tel: +351 239851830 Fax: +351 239851839
e-mail: germano@nfc.pt
www.nfc.pt
--
To send a message to E-Drug, write to: e-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug